The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
The detection of α-synuclein (α-syn) in the cerebrospinal fluid (CSF) of patients with synucleinopathy has yielded promising but inconclusive results. The aim of the present study was to determine the diagnostic value of α-syn as a biological marker for Dementia with Lewy bodies (DLB) vs. normal sub...
Guardado en:
Autores principales: | Elisabeth Kapaki, George P Paraskevas, Evangelia Emmanouilidou, Kostas Vekrellis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb56ccd77ed743bdac5b93a27a196afd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Altered serum IgG levels to α-synuclein in dementia with Lewy bodies and Alzheimer's disease.
por: Niklas K U Koehler, et al.
Publicado: (2013) -
α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox
por: Christopher Simon, et al.
Publicado: (2021) -
Advances in dementia with Lewy bodies
por: Melissa J. Armstrong
Publicado: (2021) -
Cognitive fluctuations in connection to dysgraphia: a comparison of Alzheimer’s disease with dementia Lewy bodies
por: Onofri E, et al.
Publicado: (2015) -
Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
por: Fereshtehnejad SM, et al.
Publicado: (2013)